Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy
- 1 April 1986
- journal article
- research article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 88 (2), 265-275
- https://doi.org/10.1016/0022-1759(86)90015-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.The Journal of Immunology, 1985
- An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumorsJournal of Surgical Oncology, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clonesJournal of Immunological Methods, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Accurate Identification of Experimental Pulmonary Metastases2JNCI Journal of the National Cancer Institute, 1966
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965